BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 334012)

  • 1. [Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
    Laurens A; Thevenot J; Charron D; Jorry F; Dumonchel P; Martola R
    Ann Med Interne (Paris); 1977 May; 128(5):493-6. PubMed ID: 334012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
    Misset JL; Pouillart P; Amiel JL; Schwarzenberg L; Hayat M; de Vassal F; Musset M; Belpomme D; Jasmin C; Albahary C; Depierre R; Mathé G
    Nouv Presse Med; 1975 Dec; 4(44):3117-20. PubMed ID: 768904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [4-year-observation of results of VM 26 treatment of pathologic syndromes from the lymphoma malignum group].
    Lawkowicz W; Polubiec A; Domańska B
    Acta Haematol Pol; 1975; 6(2):143-7. PubMed ID: 1098351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH; Johnson DE; Holoye PY; Samuels ML
    Cancer Treat Rep; 1977; 61(1):87-8. PubMed ID: 324624
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

  • 7. Synchronization recruitment chemotherapy in non-Hodgkin hematosarcomas.
    Schneider M; Mancini G; Fella C; Aubanel JM; Hoch M; Viguier E
    Eur J Cancer (1965); 1977; 13(4-5):429-31. PubMed ID: 326556
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T; Bender RA; Fisher RI; DeVita VT; Chabner BA; Berard CW; Norton L; Young RC
    Cancer Treat Rep; 1977 Sep; 61(6):1057-66. PubMed ID: 71205
    [No Abstract]   [Full Text] [Related]  

  • 9. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
    Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
    Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW
    Clin Bull; 1975; 5(1):20-3. PubMed ID: 776444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld ; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Feb; 3(8):447-51. PubMed ID: 4595690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 14. VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).
    Chiuten DF; Bennett JM; Creech RH; Glick J; Falkson G; Brodovsky HS; Begg CB; Muggia FM; Carbone PP
    Cancer Treat Rep; 1979 Jan; 63(1):7-11. PubMed ID: 369693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of malignant lymphoma with adriamycin.
    Gottlieb JA; Gutterman JU; McCredie KB; Rodriguez V; Frei E
    Cancer Res; 1973 Nov; 33(11):3024-8. PubMed ID: 4748450
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of the lymphomas.
    McElwain TJ
    Semin Hematol; 1974 Jan; 11(1):59-72. PubMed ID: 4859700
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dosed cyclophosphamide therapy of malignant diseases of the lymphoreticulum].
    Kühböck J; Pietschmann H
    Wien Klin Wochenschr; 1965 Nov; 77(44):883-6. PubMed ID: 5328863
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary lymphoblastic lymphoma of the breast.
    Carbone A; Volpe R; Tirelli U; Veronesi A; Galligioni E; Trovo MG; Grigoletto E
    Clin Oncol; 1982 Dec; 8(4):367-73. PubMed ID: 6897770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.